These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2948820)

  • 1. In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
    Guay D; Klicker R; Pence T; Peterson P
    Eur J Clin Microbiol; 1986 Dec; 5(6):661-3. PubMed ID: 2948820
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis.
    Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol; 1986 Feb; 5(1):48-9. PubMed ID: 2938946
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    Aubert G; Passot S; Lucht F; Dorche G
    J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
    [No Abstract]   [Full Text] [Related]  

  • 4. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE; McGeer A; Poon R
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.
    Sanyal D; Johnson AP; George RC; Edwards R; Greenwood D
    J Antimicrob Chemother; 1993 Aug; 32(2):267-78. PubMed ID: 8226428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R; Raad I
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
    Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
    Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
    Del Bene VE; John JF; Twitty JA; Lewis JW
    J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of cephalosporins against coagulase-negative staphylococci.
    Chin NX; Neu NM; Neu HC
    Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptide resistance in Staphylococcus haemolyticus during treatment with teicoplanin.
    Blans M; Troelstra A
    Infect Control Hosp Epidemiol; 2001 May; 22(5):263-4. PubMed ID: 11428432
    [No Abstract]   [Full Text] [Related]  

  • 12. Initial treatment of CAPD peritonitis: poor response with association of cefazolin and amikacin.
    Onozato ML; Caramori JC; Barretti P
    Perit Dial Int; 1999; 19(1):88-9. PubMed ID: 10201353
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
    Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
    Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of antistaphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients.
    Keller E
    Perit Dial Int; 1993; 13 Suppl 2():S367-70. PubMed ID: 8399613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT; Dulworth JK; Brackman MA
    Diagn Microbiol Infect Dis; 1991; 14(1):29-31. PubMed ID: 1826479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F; Bingen E; Lambert-Zechovsky N
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous ambulatory peritoneal dialysis (CAPD) peritonitis: the effect of antibiotic on the adherence of coagulase-negative staphylococci to silicone rubber catheter material.
    Finch RG; Edwards R; Filik R; Wilcox MH
    Perit Dial Int; 1989; 9(2):103-5. PubMed ID: 2488193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of peritoneal fluid culture results from adults and children undergoing CAPD.
    Yinnon AM; Gabay D; Raveh D; Schlesinger Y; Slotki I; Attias D; Rudensky B
    Perit Dial Int; 1999; 19(1):51-5. PubMed ID: 10201341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.